FIELD: medicine.
SUBSTANCE: invention relates to application of 2-ethyl-6-methyl-3-oxypyridine succinate for treatment of nephritis and nephropathy of various ethiology in combination with conventional therapy including rheolytic, anticoagulant and antiaggregant agents, APP inhibitors and anti-inflammatory agents.
EFFECT: effective preparation for treatment of nephritis and nephropathy.
2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING IgA-NEPHROPATHY | 2010 |
|
RU2445080C1 |
| METHOD PREDICTING CHRONIC RENAL INSUFFICIENCY AT PATIENTS WITH POSTCAPILLAROTOXIC GLOMERULONEPHRITIS | 2007 |
|
RU2333497C1 |
| METHOD FOR PREDICTION OF PESPONSE RATE TO IMMUNOSUPPRESSIVE THERAPY OF CHRONIC GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME | 2011 |
|
RU2453852C1 |
| METHOD OF TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS COMBINED WITH CHRONIC OPISTHORCHIASIS | 2010 |
|
RU2417081C1 |
| METHOD FOR PREDICTION OF SEVERITY OF GLOMERULONEPHRITIS | 2014 |
|
RU2583937C1 |
| METHOD FOR TREATING GLOMERULONEPHRITES WITH NEPHROTIC SYNDROME WITH A RELAPSING COURSE | 2020 |
|
RU2764216C1 |
| METHOD FOR TREATING PATIENTS WITH CHRONIC GLOMERULONEPHRITIS | 2001 |
|
RU2194526C1 |
| DIAGNOSTIC TECHNIQUE FOR NEPHROTIC SYNDROME WITH MINIMAL CHANGES IN CHILDREN | 2013 |
|
RU2522238C1 |
| METHOD OF ESTIMATING PROCESS ACTIVITY IN NEPHRITIS PATIENT WITH PRESERVED KIDNEY FUNCTION | 2002 |
|
RU2214603C1 |
| METHOD OF PREDICTING EFFICIENCY OF PLANNED STANDARD THERAPY OF ACUTE NEPHRITIS | 2010 |
|
RU2421126C1 |
